Brandon Tillman serves as the Managing Director of the Point of Care Business Unit. With a career spanning more than 22 years in the medical device industry, he has contributed his expertise to renowned companies such as Nelson Laboratories, ICU Medical, and currently ATL Technology. Throughout his journey, Brandon has been instrumental in assisting global medical device companies with every phase of their products' lifecycle, encompassing ideation, design, development, and seamless manufacturing of comprehensive medical solutions.
Within ATL, the Point of Care Business Unit stands as an industry leader, spearheading the creation of comprehensive patient monitoring and wearable medical solutions. The emphasis of ATL's Point of Care Business Unit is directed toward the following market sectors: Respiratory Monitoring Devices (SpO2), Hemodynamic/Pressure Monitoring Devices, Cardiac Monitoring Devices (ECG and EKG), Blood Glucose Monitoring Devices, Nerve Monitoring Devices, and Neuromonitoring Devices.
